As the end-of-the-world-as-we-know-it approached last week and the entire internet devolved into a morass of Trump headlines, the Food and Drug Administration quietly put forth proposed regulations that could drastically impact whether genetically engineered food winds up on your dinner plate in the future.
IF SAMMY JO Wilkinson had a spirit animal, it would be Marty McFly. For the past four years, the 51 year-old California resident has been using stem cell therapy to beat her secondary progressive multiple sclerosis back into remission. Gone is the paralysis to the left side of her face and the numbness in her fingers. In February, she walked for the first time in years. “I’m living in a future that everybody will have some day,” says Wilkinson, who co-founded the patient’s rights group Patients for Stem Cells. “We’re trying to tell everybody the solution is here now, we just need a logical way to bring this to patients sooner rather than later.”
Sorry, that antibacterial soap isn’t doing anything more to clean you up than any other plain bar of soap.
Although marijuana, for both its medical and recreational purposes, has been under intense scrutiny in past years, a recent announcement by the Drug Enforcement Administration–otherwise known as the DEA–continues to classify the drug as a Schedule I substance.
The FDA just approved a new, synthetic THC product for use in treating a variety of ailments, in liquid form. But despite being the first liquid THC replacement on the market, this may not be worth the buzz.
The Food and Drug Administration recently made a perhaps surprising recommendation: Don’t eat raw flour.
The US Food and Drug Administration has approved Probuphine, the first implantable drug for the treatment of opioid dependence. It’s a welcome development at a time when scores of Americans are addicted to painkillers such as OxyContin and Vicodin.